AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
ICON PLC (NASDAQ:ICLR)
139.46 USD
+4.640 3.442%| Previous Close (in USD) | 134.82 |
|---|---|
| Change | +4.640 3.442% |
| 52 W H/L (in USD) | 344.770/210.440 |
| EBITDA (in USD) | 1690.311M |
| PE Ratio | 38.87 |
| Volume | 450751 |
| Diluted Eps TTM | 8.26 |
| Total Assets (in USD) | 16989.863M |
|---|---|
| Total Liabilities (in USD) | 7749.12M |
| Revenue TTM (in USD) | 8231.984M |
| Cash (in USD) | 378.102M |
| Market Cap (in USD) | 26,546.461 M |
| Revenue Per Share TTM | 100.023 |
| Gross Profit TTM (in USD) | 2218.741M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Employees: 41150
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Dr. Steven A. Cutler MBA, Ph.D. | CEO & Director | 1960 |
| 2. | Mr. Brendan Brennan | Chief Financial Officer | 1979 |
| 3. | Jonathan Curtain | Sr. VP of Corp. & Commercial Fin. | NA |
| 4. | Mr. Thomas N. O'Leary | Chief Information Officer | NA |
| 5. | Mr. Diarmaid Cunningham | Chief Admin. Officer, Gen. Counsel, Exec. VP & Company Sec. | 1975 |
| 6. | Ms. Niamh Murphy | Director of Corp. Communications | NA |
| 7. | Mr. David Green | VP of Marketing | NA |
| 8. | Mr. Joe Cronin | Chief HR Officer | NA |
| 9. | Mr. Simon Holmes | Pres of Corp. Investments & Partnerships | 1967 |
| 10. | Ms. Dana Lynn Poff Snr. | Exec. VP of Program Management | NA |
Peers
Sector: Healthcare
Industry: Diagnostics & Research
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
TMO
Thermo Fisher Scientific Inc |
+4.590 1.152% | 400.56 | 34.710 | 23.866 | 4.622 | 4.428 | 5.293 | 20.886 |
|
DHR
Danaher Corporation |
+3.375 1.756% | 194.34 | 29.090 | 28.011 | 5.669 | 3.198 | 5.999 | 19.094 |
|
A
Agilent Technologies Inc |
+1.210 1.062% | 115.41 | 34.360 | 26.385 | 6.587 | 7.136 | 6.781 | 23.557 |
|
IDXX
IDEXX Laboratories Inc |
+1.570 0.301% | 525.58 | 49.990 | 45.662 | 11.293 | 27.850 | 11.461 | 34.457 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 567.851M | 196.68M | 382.178M | 426.989M | 368.375M |
| Minority Interest | 0M | 0M | -0.633M | 39.51M | 39.51M |
| Net Income | 506.285M | 153.185M | 330.792M | 373.986M | 322.817M |
| Selling General Administrative | 778.753M | 585.33M | 341.69M | 336.748M | 325.794M |
| Gross Profit | 2214.341M | 1508.214M | 808.032M | 831.704M | 769.49M |
| Reconciled Depreciation | 569.513M | 314.987M | 66.126M | 61.55M | 65.916M |
| Ebit | 795.237M | 608.471M | 391.967M | 433.406M | 381.065M |
| Ebitda | 1437.933M | 923.458M | 488.875M | 494.956M | 446.981M |
| Depreciation And Amortization | 642.696M | 314.987M | 96.908M | 61.55M | 65.916M |
| Operating Income | 795.237M | 608.471M | 391.967M | 433.406M | 377.118M |
| Other Operating Expenses | 6875.311M | 4872.929M | 2405.321M | 2372.433M | 2218.659M |
| Interest Expense | 229.731M | 182.423M | 15.074M | 6.417M | 13.613M |
| Tax Provision | 59.411M | 41.334M | 47.875M | 51.133M | 41.958M |
| Interest Income | 2.345M | 0.574M | 2.724M | 6.859M | 4.759M |
| Net Interest Income | -227.386M | -181.849M | -10.295M | -6.417M | -8.743M |
| Income Tax Expense | 59.411M | 41.334M | 50.753M | 51.133M | 45.558M |
| Total Revenue | 7741.386M | 5480.826M | 2797.288M | 2805.839M | 2595.777M |
| Total Operating Expenses | 1348.266M | 900.317M | 416.065M | 398.298M | 392.372M |
| Cost Of Revenue | 5527.045M | 3972.612M | 1989.256M | 1974.135M | 1826.287M |
| Total Other Income Expense Net | -227.386M | -411.791M | -9.789M | -6.417M | 0.923M |
| Net Income From Continuing Ops | 505.304M | 153.185M | 332.964M | 375.856M | 322.656M |
| Net Income Applicable To Common Shares | 505.304M | 153.185M | 327.809M | 368.938M | 322.656M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 16989.863M | 17185.278M | 17387.09M | 3465.799M | 2907.512M |
| Intangible Assets | 3855.865M | 4278.659M | 4710.843M | 66.46M | 67.894M |
| Other Current Assets | 132.105M | 137.094M | 114.323M | 53.477M | 41.517M |
| Total Liab | 7749.12M | 8687.315M | 9320.263M | 1585.13M | 1289.457M |
| Total Stockholder Equity | 9240.743M | 8497.963M | 8066.827M | 1880.669M | 1618.055M |
| Other Current Liab | 892.953M | 1046.808M | 1009.062M | 402.104M | 362.254M |
| Common Stock | 6.699M | 6.649M | 6.64M | 4.58M | 4.635M |
| Capital Stock | 6.699M | 6.649M | 6.64M | 4.58M | 4.635M |
| Retained Earnings | 2433.719M | 1821.384M | 1416.08M | 1389.982M | 1110.226M |
| Good Will | 9022.075M | 8971.67M | 9037.931M | 936.257M | 883.17M |
| Other Assets | - | 169.1M | 137.586M | 50.708M | 51.351M |
| Cash | 378.102M | 288.768M | 752.213M | 840.305M | 520.309M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 2825.608M | 2690.601M | 2478.937M | 1138.482M | 1131.252M |
| Current Deferred Revenue | 1654.507M | 1507.449M | 1323.961M | 660.931M | 366.988M |
| Net Debt | 3560.222M | 4497.063M | 4843.582M | -406.693M | -65.756M |
| Short Term Debt | 146.564M | 55.15M | 55.15M | 24.334M | 377.96M |
| Short Long Term Debt | 110.15M | 55.15M | 55.15M | - | 349.64M |
| Short Long Term Debt Total | 3938.324M | 4785.831M | 5595.795M | 433.612M | 454.553M |
| Other Stockholder Equity | 6942.669M | 6841.468M | 6735.044M | 499.107M | 579.013M |
| Property Plant Equipment | - | 504.152M | 534.567M | 258.904M | 270.064M |
| Total Current Assets | 3411.47M | 3229.066M | 2941.198M | 2114.08M | 1624.98M |
| Long Term Investments | 46.804M | 32.631M | 24.965M | 20.299M | 10.053M |
| Short Term Investments | 1.954M | 1.713M | 1.712M | 1.729M | 49.628M |
| Net Receivables | 2899.309M | 2801.491M | 2072.95M | 1224.777M | 1013.526M |
| Long Term Debt | 3665.439M | 4599.037M | 5381.162M | 348.477M | - |
| Inventory | 0M | 7.063M | 5.8M | 4.806M | 3.2M |
| Accounts Payable | 131.584M | 81.194M | 90.764M | 51.113M | 24.05M |
| Accumulated Other Comprehensive Income | -142.344M | -171.538M | -90.937M | -13M | -75.819M |
| Non Currrent Assets Other | 78.47M | 92.17M | 89.194M | 26.902M | 34.669M |
| Non Current Assets Total | 13578.393M | 13956.212M | 14445.892M | 1351.719M | 1282.532M |
| Capital Lease Obligations | 162.735M | 131.644M | 159.483M | 85.135M | 104.913M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Investments | -163.032M | -145.867M | -6.01M | -46.576M | -162.027M |
| Total Cashflows From Investing Activities | - | -145.867M | -6024.235M | -46.576M | -162.027M |
| Total Cash From Financing Activities | -844.043M | -864.173M | 5114.728M | -235.022M | -125.406M |
| Net Income | 612.335M | 505.304M | 153.185M | 331.425M | 375.856M |
| Change In Cash | 89.334M | -463.445M | -88.092M | 319.996M | 124.458M |
| Begin Period Cash Flow | 288.768M | 752.213M | 840.305M | 520.309M | 395.851M |
| End Period Cash Flow | 378.102M | 288.768M | 752.213M | 840.305M | 520.309M |
| Total Cash From Operating Activities | 1161.027M | 563.315M | 829.142M | 594.724M | 412.541M |
| Depreciation | 627.496M | 569.513M | 314.987M | 95.073M | 61.55M |
| Other Cashflows From Investing Activities | - | - | -10M | -10M | -111.382M |
| Dividends Paid | - | 35.827M | - | 13.189M | - |
| Change To Inventory | - | - | - | -1.626M | -69.699M |
| Sale Purchase Of Stock | 0M | -99.983M | -99.983M | -175M | -146.931M |
| Other Cashflows From Financing Activities | -0.016M | 110.81M | 5874.772M | 320.482M | -0.107M |
| Capital Expenditures | 140.692M | 142.16M | 93.75M | 51.055M | 50.645M |
| Change In Working Capital | -114.824M | -550.222M | 134.995M | 114.71M | -82.744M |
| Other Non Cash Items | 65.756M | 93.182M | 152.747M | -23.834M | 32.597M |
| Free Cash Flow | 1020.335M | 421.155M | 735.392M | 543.669M | 361.896M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | WCM Inv Mgt Focused Growth Intl | 1 year ago | 2733866 |
| 2. | WCM Focused International Growth Instl | 1 year ago | 2733866 |
| 3. | VA CollegeAmerica Amcap 529A | 1 year ago | 1387244 |
| 4. | Capital Group AMCAP Composite | 1 year ago | 1387244 |
| 5. | Ninety One GSF Glb Frchs I Acc USD | 1 year ago | 1111407 |
| 6. | Ninety One Global Franchise | 1 year ago | 1111407 |
| 7. | JHancock Disciplined Value Mid Cap I | 1 year ago | 970717 |
| 8. | US Small-Cap Growth II Equity Comp | 1 year ago | 868000 |
| 9. | T. Rowe Price New Horizons | 1 year ago | 868000 |
| 10. | MFS Large Cap Growth Equity | 1 year ago | 799217 |
| 11. | MFS Mid Cap Growth Equity | 1 year ago | 750542 |
| 12. | MFS Mid Cap Growth A | 1 year ago | 750542 |
| 13. | Templeton Growth A | 1 year ago | 729698 |
| 14. | Baron Opp. Small Cap Growth Strategy | 1 year ago | 700000 |
| 15. | Baron Small Cap Retail | 1 year ago | 700000 |
| 16. | Victory Sycamore Established Value R | 1 year ago | 695000 |
| 17. | MFS Massachusetts Inv Gr Stk A | 1 year ago | 635591 |
| 18. | MFS Growth Equity | 1 year ago | 626958 |
| 19. | MFS Growth B | 1 year ago | 622670 |
| 20. | JHancock Disciplined Value I | 1 year ago | 606923 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | WCM Investment Management | 1 year ago | 6717813 |
| 2. | Massachusetts Financial Services Company | 1 year ago | 5313457 |
| 3. | Wellington Management Company LLP | 1 year ago | 3427415 |
| 4. | FMR Inc | 1 year ago | 3025284 |
| 5. | Lazard Asset Management LLC | 1 year ago | 2761425 |
| 6. | Ninety One UK Limited | 1 year ago | 2645811 |
| 7. | Boston Partners Global Investors, Inc | 1 year ago | 2628805 |
| 8. | Capital Research Global Investors | 1 year ago | 2200417 |
| 9. | Amvescap Plc. | 1 year ago | 1965902 |
| 10. | BlackRock Inc | 1 year ago | 1806591 |
| 11. | T. Rowe Price Associates, Inc. | 1 year ago | 1743683 |
| 12. | Franklin Resources Inc | 1 year ago | 1684269 |
| 13. | ClearBridge Advisors, LLC | 1 year ago | 1674727 |
| 14. | Comgest Global Investors SAS | 1 year ago | 1543811 |
| 15. | Goldman Sachs Group Inc | 1 year ago | 1480372 |
| 16. | AllianceBernstein L.P. | 1 year ago | 1474610 |
| 17. | Sustainable Growth Advisers, LP | 1 year ago | 1304448 |
| 18. | BlueSpruce Investments, LP | 1 year ago | 1281244 |
| 19. | Polen Capital | 1 year ago | 1191615 |
| 20. | HHG PLC | 1 year ago | 1176749 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...